Studies of compliance with delayed-release mesalazine therapy in patients with inflammatory bowel disease.

@article{Shale2003StudiesOC,
  title={Studies of compliance with delayed-release mesalazine therapy in patients with inflammatory bowel disease.},
  author={Matthew J H Shale and Stuart A. Riley},
  journal={Alimentary pharmacology & therapeutics},
  year={2003},
  volume={18 2},
  pages={191-8}
}
BACKGROUND Non-compliance with maintenance mesalazine therapy may be a risk factor for relapse in inflammatory bowel disease, but the prevalence and determinants of non-compliance are unknown. AIM To study the prevalence and determinants of non-compliance in patients with inflammatory bowel disease. METHODS Out-patients receiving delayed-release mesalazine were studied. Compliance was determined by direct enquiry and by analysis of urine samples for 5-aminosalicylic acid/N-acetyl-5… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 96 extracted citations

Similar Papers

Loading similar papers…